Boehringer shutters problematic Ohio plant

Share this article:

Money is the reason behind Boehringer Ingelheim shutting down its Ben Venue labs in Bedford, OH. The company announced Monday that it would have to put far too much money into the site to bring it up to manufacturing code. The changes would cost the company around $700 million in operating losses in addition to requiring investment that goes beyond the $350 million it has already put towards getting the site in functional condition. The site's problems are noteworthy, with the Cleveland Plain Dealer counting around 40 recalls for drugs manufactured at the plant between 2002 and January 2013, and the FDA finding “a reasonable probability that use of the recalled drugs would cause ‘serious adverse health consequences or death,'” in nine of those cases.

The plant's manufacturing issues included storage of urine at the site as well as glass and metal contaminants. The company will being laying off the almost 1,100 workers employed at the labs between now and 2014, affecting its ability to make BI's products as well as J&J's cancer medication Doxil among others.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.